Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cyclacel
Biotech
Ex-Eisai leader to be new NextPoint CEO—Chutes & Ladders
Ex-Eisai leader Cheung tapped as new NextPoint chief. Gregory to lead Regeneron's new cell therapy unit following 2seventy moves. Sanofi swaps CFOs.
Max Bayer
,
Gabrielle Masson
Feb 2, 2024 9:30am
Cyclacel passes phase 3 leukemia drug rights back to Daiichi
Nov 10, 2022 10:05am
Phase 1 data backs Cyclacel’s plans for CDK2/9 inhibitor
Apr 16, 2018 9:38am
Cyclacel AML drug fails phase 3, wiping 30% off stock
Feb 23, 2017 8:37am
